Director/PDMR Shareholding

RNS Number : 8685Q
GlaxoSmithKline PLC
02 December 2016
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr S Dingemans

b)

Position/status

Chief Financial Officer

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

b)

Nature of the transaction

Acquisition of Ordinary Shares on 1 December 2016 following the exercise of options granted on 30 October 2013 at the option price of £12.47 per Ordinary Share under the Company's ShareSave Plan. 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£12.47

216

d)

Aggregated information

 

Aggregated volume Price

n/a (single transaction)

 

e)

Date of the transaction

2016-12-01

f)

Place of the transaction

 

London Stock Exchange (XLON)

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHELLFBQLFZFBV

Companies

GSK (GSK)
UK 100

Latest directors dealings